Oncology Institute
(NASDAQ) TOI
Oncology Institute Financials at a Glance
Market Cap
$511.91M
Revenue (TTM)
$545.76M
Net Income (TTM)
-$43.51M
EPS (TTM)
-$0.38
P/E Ratio
-13.64
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$5.41
Volume
5,202,825.868
Open
$5.15
Price
$5.41
Volume
5,202,825.868
Open
$5.15
Previous Close
$5.39
Daily Range
$5.04 - $5.42
52-Week Range
$2.02 - $5.58
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$5.41
Volume
5,202,825.868
Open
$5.15
Previous Close
$5.39
Daily Range
$5.04 - $5.42
52-Week Range
$2.02 - $5.58
Estimated Earnings Date
Aug 12, 2026
TOI News
TOI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncology Institute
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
641
CEO
Daniel Virnich, MD, MBA
Website
www.theoncologyinstitute.comHeadquarters
Cerritos, CA 90703, US
TOI Financials
Key Financial Metrics (TTM)
Gross Margin
14.82%
Operating Margin
-5.99%
Net Income Margin
-7.97%
Return on Equity
326.77%
Return on Capital
-41.02%
Return on Assets
-25.87%
Earnings Yield
-7.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$511.91M
Shares Outstanding
99.98M
Volume
5.20M
Avg. Volume
1.63M
Financials (TTM)
Gross Profit
$80.89M
Operating Income
-$32.69M
EBITDA
-$29.23M
Operating Cash Flow
-$21.81M
Capital Expenditure
-$3.91M
Free Cash Flow
-$25.73M
Cash & ST Invst.
$30.28M
Total Debt
$104.86M
Oncology Institute Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$147.44M
+41.2%
Gross Profit
$21.70M
+25.8%
Gross Margin
14.72%
N/A
Market Cap
$511.91M
N/A
Market Cap/Employee
$620.50K
N/A
Employees
825
N/A
Net Income
-$2.49M
+87.3%
EBITDA
$1.06M
+108.7%
Quarterly Fundamentals
Total Cash
$30.28M
-23.8%
Total Debt
$104.86M
+2.5%
Accounts Receivable
$59.45M
+19.7%
Inventory
$24.29M
+97.4%
Long Term Debt
$97.45M
+2.1%
Short Term Debt
$7.40M
+8.6%
Return on Assets
-25.87%
N/A
Return on Invested Capital
-36.77%
N/A
Free Cash Flow
-$3.26M
+38.7%
Operating Cash Flow
-$2.22M
+55.6%